Compare WAL & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WAL | BAX |
|---|---|---|
| Founded | 1994 | 1931 |
| Country | United States | United States |
| Employees | 3524 | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 10.2B |
| IPO Year | N/A | 1994 |
| Metric | WAL | BAX |
|---|---|---|
| Price | $69.62 | $18.06 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 16 | 9 |
| Target Price | ★ $98.40 | $22.38 |
| AVG Volume (30 Days) | 1.7M | ★ 9.2M |
| Earning Date | 01-01-0001 | 05-14-2026 |
| Dividend Yield | ★ 2.32% | 0.23% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $11,244,000,000.00 |
| Revenue This Year | $20.16 | $1.90 |
| Revenue Next Year | $8.63 | $2.09 |
| P/E Ratio | $10.88 | ★ N/A |
| Revenue Growth | N/A | ★ 5.72 |
| 52 Week Low | $57.05 | $17.07 |
| 52 Week High | $97.23 | $35.03 |
| Indicator | WAL | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 25.83 | 37.46 |
| Support Level | N/A | $17.69 |
| Resistance Level | $89.70 | $19.31 |
| Average True Range (ATR) | 3.85 | 0.71 |
| MACD | -1.95 | -0.34 |
| Stochastic Oscillator | 5.21 | 19.91 |
Western Alliance Bancorp provides a full spectrum of customized loan, deposit, and treasury management capabilities, including funds transfer and other digital payment offerings. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.